Autor:	Ogbuagu Chukwuanugo Nkemakonam, Ogbuagu Ekenechukwu Nkiloka, Okoh Emeka Emmanuel
Rok vydání:	2021
Zdroj:	International Journal of Health Sciences and Research. 11:1-8
ISSN:	2249-9571
Popis:	Background: Antiretroviral therapy (ART) has significantly increased the lifespan of people living with HIV. Currently, fixed dosed combination therapy (Tenofovir, Lamivudine, and Dolutegravir) is being introduced in most countries in the Sub- Saharan Africa. There is need for a clinical and immunological assessment of HIV patients transitioned to this new therapy over a period of 2 years. Objectives: To determine the proportion of patients whose viral load was suppressed to
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::fac82e26c8247056d86ec52ae8b5879d https://doi.org/10.52403/ijhsr.20211201 Zobrazit plný text záznamu